eISSN: 2353-9461
ISSN: 0860-7796
BioTechnologia
Current issue Archive About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors
1/2019
vol. 100
 
Share:
Share:
more
 
 
abstract:
RESEARCH PAPERS

Synthesis and in vitro anticancer activity of N-alkyl phosphoramidate monoesters of 3’-azido-3’-deoxythymidine (AZT)

Ewa Czajkowska-Wojciechowska, Aleksandra Singh, Roksana Trznadel, Piotr Ruszkowski, Lech Celewicz

BioTechnologia vol. 100 (1) C pp. 81–88 C 2019
Online publish date: 2019/03/27
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
In this study, a series of novel N-alkyl phosphoramidate monoesters of 3’-azido-3’-deoxythymidine (AZT) were synthesized using two methods. The synthesized phosphoramidates 7a–e were evaluated for their cytotoxic activity in three human cancer cell lines (cervical cancer (HeLa), nasopharyngeal cancer (KB), and breast cancer (MCF-7)) and a normal dermal fibroblast cell line (HDF) using sulforhodamine B assay. Among the synthesized phosphoramidates, the highest cytotoxic activity was demonstrated by phosphoramidate 7d with the N-n-propyl substituent in all the examined cancer cell lines, and its activity was found to be about two fold higher than that of the parent nucleoside (AZT). Phosphoramidate 7d showed not only a high cytotoxic activity against cancer cell lines but also a low toxicity against normal fibroblast cells; its selectivity index was >3 for all the investigated cancer cell lines. A slightly lower cytotoxic activity was shown by phosphoramidates 7a, 7b, and 7e, whereas phosphoramidate 7c with the N-(2,2,2-trifluoroethyl) substituent exhibited the least cytotoxic activity in all the cell lines used.
keywords:

N-alkyl phosphoramidate monoesters of 3’-azido-3’-deoxythymidine, cytotoxic activity, human cancer cell lines – HeLa, KB, MCF-7, normal human cell line – HDF

 
Stosujemy się do standardu HONcode dla wiarygodnej informacji zdrowotnej This site complies with the HONcode standard for trustworthy health information: verify here